The interventional cardiology team at the Detroit Medical Center’s Heart Hospital in Detroit is now offering patients with coronary artery disease a new dissolving heart stent treatment option.
Recently approved by the Food and Drug Administration, the Absorb bioresorbable vascular scaffold stent opens clogged arteries to restore blood flow and then gradually dissolves in the body.
The stent disappears in about three years, while traditional stents, which are made of metal, are permanent.
“The benefit of a bioresorbable stent comes from not implanting a permanent metal prosthesis,” says Dr. Amir Kaki, medical director of the Cardiac Catheterization Laboratories at DMC Heart Hospital. “After it has dissolved, the patient’s artery is restored to a natural state.”
To ensure proper implant technique on patients with coronary artery disease, which affects 15 million people in the United States, Kaki says DMC Heart Hospital’s interventional cardiology team underwent extensive training on the new device.
Founded in 2014, the DMC Heart Hospital, 311 Mack Ave., features six floors of clinical care, two cardiac catheterization labs, two electrophysiology labs, two cardiac swing labs, a cardiac testing suite, and more.
The hospital is part of the Detroit Medical Center network, which also includes DMC Children’s Hospital of Michigan, DMC Detroit Receiving Hospital, DMC Harper University Hospital, DMC Huron Valley-Sinai Hospital, DMC Hutzel Women’s Hospital, DMC Rehabilitation Institute of Michigan, and DMC Sinai-Grace Hospital.